EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Irradiation fields and doses in glioblastoma multiforme: are current standards adequate?



Irradiation fields and doses in glioblastoma multiforme: are current standards adequate?



Tumori 87(2): 85-90



Aims and background: The optimum conventional radiotherapy in glioblastoma multiforme patients has not been clearly defined by prospective trials. To better characterize a standard radiotherapy in glioblastoma multiforme, the impact on survival of different fields and doses was analyzed in a retrospective single center series. Methods: One hundred and forty-seven patients with glioblastoma multiforme, submitted to biopsy only (n = 15), subtotal (n = 48) or total resection (n = 82) and who completed the planned postsurgical radiotherapy, were considered. The median age was 57 years, the male/female ratio 1.5/1, and the performance status gtoreq70 in 76%. Whole brain irradiation, followed by a boost to partial brain, was used in 75 cases with a whole brain dose of 44-50 Gy (median, 46) and a partial brain dose of 56-70 Gy (median, 60 Gy). Partial brain irradiation alone was used in 72 patients with a dose of 56-70 Gy (median, 61 Gy). Ninety-eight patients received 56-60 Gy (median, 59 Gy) to partial brain whereas 49 patients received 61-70 Gy (median, 63 Gy). Results: There was an almost significantly longer survival in patients irradiated to the partial brain alone with respect to those also receiving whole brain radiotherapy (P = 0.056). Doses >60 Gy significantly prolonged survival (P = 0.006). Multivariate analysis confirmed that the impact on survival of radiation dose was independent of age, performance status, extent of surgery, field of irradiation and the use of chemotherapy. The extent of irradiation field was not independently related to improved survival. Conclusions: Our retrospective findings suggest that we reflect on the adequacy of the current standard irradiation parameters. Well-designed prospective trials are necessary to standardize the radiotherapy control group in patients with glioblastoma multiforme to be compared in phase III trials with innovative therapeutic approaches.

(PDF emailed within 1 workday: $29.90)

Accession: 010885616

Download citation: RISBibTeXText

PMID: 11401212



Related references

Standards of care and novel approaches in the management of glioblastoma multiforme. Chinese Journal of Cancer 33(1): 32-39, 2014

CT-Guided interstitial HDR Brachytherapy for recurrent glioblastoma Multiforme - Long-term results FT CT-gestutzte interstitielle HDR-Brachytherapie bei glioblastoma-multiforme-rezidiven. Langzeitergebnisse. 2007

Treating glioblastoma multiforme with electrical fields. World Neurosurgery 74(2-3): 208-211, 2011

Re-irradiation for recurrent glioblastoma multiforme. Chinese Clinical Oncology 6(4): 36-36, 2017

Re-irradiation with radiosurgery for recurrent glioblastoma multiforme. Technology in Cancer Research & Treatment 10(3): 253-258, 2011

Management of glioblastoma multiforme by irradiation and chemotherapy. Illinois Medical Journal 163(1): 30-34, 1983

Treatment of glioblastoma multiforme with high doses of carmustine intracavitary, in an infant. Child's Nervous System 28(5): 747-750, 2013

Role of Re-irradiation in Salvage Treatment of Glioblastoma Multiforme. Asian Pacific Journal of Cancer Prevention 17(5): 2729-2730, 2016

Conventional vs accelerated CT-planned irradiation of glioblastoma multiforme. Radiotherapy & Oncology 56(Supplement 1): S27, September, 2000

Postoperative radiotherapy of glioblastoma multiforme - Analysis and critical assessment of different treatment strategies and predictive factors FT Postoperative Strahlentherapie des glioblastoma multiforme. Analyse pradiktiver faktoren. 2007

Current management of glioblastoma multiforme. Seminars in Oncology 31(5): 635-644, 2004

Glioblastoma multiforme of the cerebellum five decades after irradiation of a cerebellar tumor. Journal of Neuro-Oncology 7(4): 339-344, 1989

Fast-neutron irradiation of glioblastoma multiforme. Neuropathological analysis. Journal of Neurosurgery 49(1): 1-12, 1978

Carboplatin chemotherapy before irradiation in newly diagnosed glioblastoma multiforme. American Journal of Clinical Oncology 21(4): 338-340, 1998

Stereotactically guided fractionated re-irradiation in recurrent glioblastoma multiforme. Journal of Neuro-Oncology 74(2): 167-171, 2005